Imunon

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$3.55-$35.84
Market Cap
$11.4M
Shares Short
158,811

Financials

See more
Revenue (12 Mos)
$125,000
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$2.7M
Diluted EPS
-$12.53

News

See more

Yahoo Finance • last month

IMUNON Reports Third Quarter 2025 Financial Results and Provides Business Update

Yahoo Finance • last month

IMUNON Public Webcast Highlights Resilience and Innovation in Pursuit of the First Approved Immunotherapy for Ovarian Cancer

Yahoo Finance • last month

IMUNON R&D Day Showcases Clinical Progress of Its Novel Immunotherapy, Phase 3 Trial and Significant Potential for Women with Ovarian Cancer

Yahoo Finance • 2 months ago

IMUNON R&D Day: Opportunity to Hear Clinical Trial Investigators Discuss Significant Potential of IMNN-001 to Redefine Ovarian Cancer Treatment

About

CEO
Dr. Stacy R. Lindborg Ph.D.
CFO
Ms. Kimberly Graper
Address
997 Lenox Drive, Lawrenceville, NJ, United States, 08648
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
25